TY - JOUR TI - The AXL-PYK2-PKCα axis as a nexus of stemness circuits in TNBC AU - Khera, Lohit AU - Vinik, Yaron AU - Maina, Flavio AU - Lev, Sima T2 - Life Science Alliance AB - Cancer stem cells (CSCs) are implicated in tumor initiation, metastasis and drug resistance, and considered as attractive targets for cancer therapy. Here we identified a clinically relevant signaling nexus mediated by AXL receptor, PYK2 and PKCα and show its impact on stemness in TNBC. AXL, PYK2, and PKCα expression correlates with stemness signature in basal-like breast cancer patients, and their depletion in multiple mesenchymal TNBC cell lines markedly reduced the number of mammosphere-forming cells and cells harboring CSCs characteristic markers. Knockdown of PYK2 reduced the levels of AXL, PKCα, FRA1, and PYK2 proteins, and similar trend was obtained upon PKCα depletion. PYK2 depletion decreased AXL transcription through feedback loops mediated by FRA1 and TAZ, whereas PKCα inhibition induced redistribution of AXL to endosomal/lysosomal compartment and enhanced its degradation. PYK2 and PKCα cooperate at a convergence point of multiple stemness-inducing pathways to regulate AXL levels and concomitantly the levels/activation of STAT3, TAZ, FRA1, and SMAD3 as well as the pluripotent transcription factors Nanog and Oct4. Induction of stemness in TNBC sensitized cells to PYK2 and PKCα inhibition suggesting that targeting the AXL-PYK2-PKCα circuit could be an efficient strategy to eliminate CSCs in TNBC. DA - 2021/06/01/ PY - 2021 DO - 10.26508/lsa.202000985 DP - www.life-science-alliance.org VL - 4 IS - 6 LA - en SN - 2575-1077 UR - https://www.life-science-alliance.org/content/4/6/e202000985 Y2 - 2021/03/31/16:58:01 ER -